JP2020522254A5 - - Google Patents

Info

Publication number

JP2020522254A5

JP2020522254A5 JP2019566237A JP2019566237A JP2020522254A5 JP 2020522254 A5 JP2020522254 A5 JP 2020522254A5 JP 2019566237 A JP2019566237 A JP 2019566237A JP 2019566237 A JP2019566237 A JP 2019566237A JP 2020522254 A5 JP2020522254 A5 JP 2020522254A5

Authority

JP

Japan

Prior art keywords

mpl

amino acid

chain variable

polypeptide

heavy chain

Prior art date

2018-05-31

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 102100000250 MPL Human genes 0.000 claims description 151
• 108060005135 MPL Proteins 0.000 claims description 151
• 230000027455 binding Effects 0.000 claims description 86
• 229920001184 polypeptide Polymers 0.000 claims description 54
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 49
• 102100002977 CDR1 Human genes 0.000 claims description 48
• 108090001123 antibodies Proteins 0.000 claims description 46
• 102000004965 antibodies Human genes 0.000 claims description 46
• 239000000427 antigen Substances 0.000 claims description 43
• 102000038129 antigens Human genes 0.000 claims description 43
• 108091007172 antigens Proteins 0.000 claims description 43
• 210000004027 cells Anatomy 0.000 claims description 20
• 201000011510 cancer Diseases 0.000 claims description 14
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 10
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 10
• 102100005499 PTPRC Human genes 0.000 claims description 9
• 101700059076 PTPRC Proteins 0.000 claims description 9
• 238000006471 dimerization reaction Methods 0.000 claims description 9
• 206010028980 Neoplasm Diseases 0.000 claims description 8
• 210000002865 immune cell Anatomy 0.000 claims description 5
• 206010000880 Acute myeloid leukaemia Diseases 0.000 claims description 4
• 102000003777 Interleukin-1 beta Human genes 0.000 claims description 4
• 108090000193 Interleukin-1 beta Proteins 0.000 claims description 4
• 208000008456 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Diseases 0.000 claims description 4
• 208000007046 Leukemia, Myeloid, Acute Diseases 0.000 claims description 4
• 206010025323 Lymphomas Diseases 0.000 claims description 4
• 206010025310 Other lymphomas Diseases 0.000 claims description 4
• 108091005711 TGF-beta receptors Proteins 0.000 claims description 4
• 102000016715 Transforming Growth Factor beta Receptors Human genes 0.000 claims description 4
• 230000003042 antagnostic Effects 0.000 claims description 4
• 239000005557 antagonist Substances 0.000 claims description 4
• 201000006934 chronic myeloid leukemia Diseases 0.000 claims description 4
• 239000008194 pharmaceutical composition Substances 0.000 claims description 4
• 208000003950 B-Cell Lymphoma Diseases 0.000 claims description 3
• 210000003719 B-Lymphocytes Anatomy 0.000 claims description 3
• 101710013430 DEFB4A Proteins 0.000 claims description 3
• 101700013756 ELK4 Proteins 0.000 claims description 3
• 230000035693 Fab Effects 0.000 claims description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
• 210000000265 Leukocytes Anatomy 0.000 claims description 3
• 206010029592 Non-Hodgkin's lymphomas Diseases 0.000 claims description 3
• 101710004306 Os04g0364800 Proteins 0.000 claims description 3
• 101710028881 PSAP Proteins 0.000 claims description 3
• 102100005492 PTPRH Human genes 0.000 claims description 3
• 101700014840 PTPRH Proteins 0.000 claims description 3
• 102100004021 PTPRT Human genes 0.000 claims description 3
• 101700069283 PTPRT Proteins 0.000 claims description 3
• 101700050881 SCLT1 Proteins 0.000 claims description 3
• 210000001744 T-Lymphocytes Anatomy 0.000 claims description 3
• 239000000430 cytokine receptor antagonist Substances 0.000 claims description 3
• 239000000203 mixture Substances 0.000 claims description 3
• 229920001469 poly(aryloxy)thionylphosphazene Polymers 0.000 claims description 3
• 101700044612 sap1 Proteins 0.000 claims description 3
• 108010032595 Antibody Binding Sites Proteins 0.000 claims description 2
• 241000282836 Camelus dromedarius Species 0.000 claims description 2
• 102000004190 Enzymes Human genes 0.000 claims description 2
• 108090000790 Enzymes Proteins 0.000 claims description 2
• 206010020243 Hodgkin's disease Diseases 0.000 claims description 2
• 201000006743 Hodgkin's lymphoma Diseases 0.000 claims description 2
• 208000006557 Lymphoma, B-Cell, Marginal Zone Diseases 0.000 claims description 2
• 108010070144 Single-Chain Antibodies Proteins 0.000 claims description 2
• 102000005632 Single-Chain Antibodies Human genes 0.000 claims description 2
• 231100000765 Toxin Toxicity 0.000 claims description 2
• 239000003795 chemical substances by application Substances 0.000 claims description 2
• 201000003444 follicular lymphoma Diseases 0.000 claims description 2
• 201000009277 hairy cell leukemia Diseases 0.000 claims description 2
• 230000003993 interaction Effects 0.000 claims description 2
• 238000002372 labelling Methods 0.000 claims description 2
• 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims description 2
• 239000003053 toxin Substances 0.000 claims description 2
• 208000000429 Leukemia, Lymphocytic, Chronic, B-Cell Diseases 0.000 claims 2
• 230000036210 malignancy Effects 0.000 claims 2
• 208000009899 Burkitt Lymphoma Diseases 0.000 claims 1
• 206010008958 Chronic lymphocytic leukaemia Diseases 0.000 claims 1
• 206010012818 Diffuse large B-cell lymphoma Diseases 0.000 claims 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 claims 1
• 206010052178 Lymphocytic lymphoma Diseases 0.000 claims 1
• 208000003747 Lymphoid Leukemia Diseases 0.000 claims 1
• 102100013253 MS4A3 Human genes 0.000 claims 1
• 101700020723 MS4A3 Proteins 0.000 claims 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
• 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
• 230000001154 acute Effects 0.000 claims 1
• 201000006439 lymphocytic leukemia Diseases 0.000 claims 1
• 201000009251 multiple myeloma Diseases 0.000 claims 1
• 201000003793 myelodysplastic syndrome Diseases 0.000 claims 1
• 239000000825 pharmaceutical preparation Substances 0.000 claims 1
• 238000006467 substitution reaction Methods 0.000 description 42
• 230000004048 modification Effects 0.000 description 40
• 238000006011 modification reaction Methods 0.000 description 40
• 102100019516 JAK2 Human genes 0.000 description 21
• 101700016050 JAK2 Proteins 0.000 description 21
• 150000001413 amino acids Chemical class 0.000 description 20
• 238000003780 insertion Methods 0.000 description 20
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
• 102000018358 Immunoglobulins Human genes 0.000 description 7
• 108060003951 Immunoglobulins Proteins 0.000 description 7
• 230000035772 mutation Effects 0.000 description 6
• 102000002727 Protein Tyrosine Phosphatases Human genes 0.000 description 5
• 108020000494 Protein Tyrosine Phosphatases Proteins 0.000 description 5
• 230000000694 effects Effects 0.000 description 5
• 230000000875 corresponding Effects 0.000 description 4
• 230000003394 haemopoietic Effects 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 206010028537 Myelofibrosis Diseases 0.000 description 3
• 208000003476 Primary Myelofibrosis Diseases 0.000 description 3
• 229920002397 Thermoplastic olefin Polymers 0.000 description 3
• 108020004707 nucleic acids Proteins 0.000 description 3
• 150000007523 nucleic acids Chemical class 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N Tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
• 201000005510 acute lymphocytic leukemia Diseases 0.000 description 2
• 239000002876 beta blocker Substances 0.000 description 2
• 230000014509 gene expression Effects 0.000 description 2
• 206010016654 Fibrosis Diseases 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 206010024324 Leukaemias Diseases 0.000 description 1
• 206010026798 Mantle cell lymphomas Diseases 0.000 description 1
• 101710011268 TGFBR1 Proteins 0.000 description 1
• 102100003993 TGFBR1 Human genes 0.000 description 1
• 102000036902 Thrombopoietin Human genes 0.000 description 1
• 108010041111 Thrombopoietin Proteins 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 108010072668 atezolizumab Proteins 0.000 description 1
• 230000001684 chronic Effects 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 230000002489 hematologic Effects 0.000 description 1
• 125000005842 heteroatoms Chemical group 0.000 description 1
• 230000003834 intracellular Effects 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000000546 pharmaceutic aid Substances 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000000865 phosphorylative Effects 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 201000010874 syndrome Diseases 0.000 description 1